COG vs. KOO, RENX, INHC, FDBK, IQAI, TRLS, DVRG, SENS, EMIS, and CRW
Should you be buying Cambridge Cognition stock or one of its competitors? The main competitors of Cambridge Cognition include Kooth (KOO), Renalytix (RENX), Induction Healthcare Group (INHC), Feedback (FDBK), IQ-AI (IQAI), Trellus Health (TRLS), DeepVerge (DVRG), Sensyne Health (SENS), EMIS Group (EMIS), and Craneware (CRW). These companies are all part of the "health information services" industry.
Cambridge Cognition vs. Its Competitors
Kooth (LON:KOO) and Cambridge Cognition (LON:COG) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their dividends, media sentiment, risk, institutional ownership, analyst recommendations, earnings, valuation and profitability.
In the previous week, Kooth and Kooth both had 1 articles in the media. Kooth's average media sentiment score of 0.00 equaled Cambridge Cognition'saverage media sentiment score.
Kooth currently has a consensus target price of GBX 365, indicating a potential upside of 170.37%. Given Kooth's stronger consensus rating and higher probable upside, equities analysts plainly believe Kooth is more favorable than Cambridge Cognition.
Kooth has higher revenue and earnings than Cambridge Cognition. Cambridge Cognition is trading at a lower price-to-earnings ratio than Kooth, indicating that it is currently the more affordable of the two stocks.
Kooth has a beta of 0.71, meaning that its share price is 29% less volatile than the S&P 500. Comparatively, Cambridge Cognition has a beta of 0.72, meaning that its share price is 28% less volatile than the S&P 500.
26.4% of Kooth shares are held by institutional investors. Comparatively, 15.8% of Cambridge Cognition shares are held by institutional investors. 30.7% of Kooth shares are held by company insiders. Comparatively, 3.4% of Cambridge Cognition shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
Kooth has a net margin of 7.89% compared to Cambridge Cognition's net margin of -10.07%. Kooth's return on equity of 18.59% beat Cambridge Cognition's return on equity.
Summary
Kooth beats Cambridge Cognition on 12 of the 14 factors compared between the two stocks.
Get Cambridge Cognition News Delivered to You Automatically
Sign up to receive the latest news and ratings for COG and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding COG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Cambridge Cognition Competitors List
Related Companies and Tools
This page (LON:COG) was last updated on 10/17/2025 by MarketBeat.com Staff